Going There with JOSEPH: Navigating Our Body’s Response to Stress and Anxiety

The sisterly band explores their experiences with mental health on new album The Sun

going there joseph podcast with dr mike anxiety stress
Going There with Joseph, photo by Shervin Lainez

    Listen via: Apple Podcasts | Spotify | Pandora | Stitcher | Google | Pocket Casts | Radio Public | RSS

    On this episode of Going There, Dr. Mike speaks with sisters Natalie Closner Schepman, Allison Closner, and Meegan Closner, together known as the band JOSEPH.

    The sisters join host Dr. Mike Friedman to talk about how we interpret the physical sensations associated with panic attacks and stress. It’s something the band touches on in their new song, “Nervous System,” which deals with a description of intense anxiety experienced by one of the members themselves.

    “That song came from a moment that I was experiencing some anxiety at the same time as my partner at the time,” Allison explains. “I was balancing that feeling of, how do I help them while also needing to help myself in this moment?”

    Hailing from Portland, Oregon, the indie pop outfit has appeared on several late night shows, toured the festival circuit, and even supported The Shins on their Oh, Inverted World anniversary tour. The band has recently released their latest album, The Sun, which they’re currently touring North America behind.


    Get JOSEPH Tickets Here

    Listen to JOSEPH discuss how anxiety affects the body and more above and watch a snippet of the interview below. Then make sure to like, review, and subscribe to Going There with Dr. Mike, presented by the Consequence Podcast Network and Sound Mind Live, wherever you get your podcasts.

    If you’re having trouble seeing the video above, watch on YouTube.

    Those in need of mental health assistance can also check out the Sound Mind Live resources page for a list of helplines, community programs, therapy links, and more.

    Season 4 of Going There with Dr. Mike is brought to you by AbbVie, who is driving the pursuit of better mental health. Over the last 30 years, AbbVie’s scientists and clinicians have worked to tackle the complexity of mental illness and today offer a portfolio of medicines and a pipeline of innovation that spans depression, anxiety, bipolar 1 disorder, and schizophrenia. To learn more about AbbVie’s work to support individuals throughout their mental health journey, please visit or follow at AbbVie on TwitterFacebookInstagramYouTube, and LinkedIn.

Latest Stories